首页/数据集/Dataset from A Phase 3 Randomized, Double Blind, Placebo-Controlled Multicenter Study Of The Analgesic Efficacy And Safety Of Tanezumab In Patients With Osteoarthritis Of The Knee

Dataset from A Phase 3 Randomized, Double Blind, Placebo-Controlled Multicenter Study Of The Analgesic Efficacy And Safety Of Tanezumab In Patients With Osteoarthritis Of The Knee

NIAID Data Ecosystem2026-05-10 收录

关节炎临床试验

镇痛药物安全性评价

数据链接：

https://doi.org/10.25934/00005045 数据链接链接失效反馈

官方服务：

资源简介：

Test the efficacy and safety of 3 doses in Osteoarthritis of the knee in patients.

应用场景：

创建时间：

2025-09-26

补充替代医学

关节炎临床试验

Values are means (SD) unless otherwise indicated.*Mean total (SD) of other therapies tried previously from a list of 15 common forms of complementary or alternative medicine (CAM). Most commonly used

Figshare2015-12-02 更新40

A Phase 2 Open-Label, Noncomparative, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study

关节炎临床试验

药物长期疗效评估

The purpose of this study is to evaluate the long-term safety and efficacy of ASP015K in subjects with Rheumatoid Arthritis (RA) who have completed a preceding Phase 2 ASP015K RA study.

DataCite Commons2025-02-10 更新00

A Randomized, Placebo Controlled, Double-blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate, Compared to Methotrexate Monotherapy, in Patients With Active Rheumatoid Arthritis

关节炎临床试验

生物制剂疗效评估

This study evaluated the efficacy and safety of rituximab in patients with active rheumatoid arthritis (RA).

DataCite Commons2025-04-01 更新00

Dataset from A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 Given With Methotrexate (MTX) in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response or Intolerance to Anti-TNF Biologic Therapy

关节炎临床试验

JAK抑制剂疗效

The primary objective is to compare the safety and efficacy of multiple doses of ABT-494 versus placebo in moderately to severely active RA subjects on stable background MTX therapy with inadequate re

NIAID Data Ecosystem10

Baseline clinical characteristics of the patients selected from two U-Act-Early study arms.

关节炎临床试验

患者基线特征

Baseline clinical characteristics of the patients selected from two U-Act-Early study arms.

Figshare2020-12-10 更新00